The SynCorp Saga: Books 1-3

Product Information

Medical Writing at Syncorp Health includes Regulatory, Marketing, Clinical writing services including publications. The team has expertise in developing documents in accordance to the SOPs and customized per sponsor’s requirements that comply to ICH GCP guidelines. Co-Founder, Board member and Vice President, Business Operations at Syncorp Health. He brings over eighteen (18) plus years of experience, worked in Clinical Research Organizations (CRO), Pharmaceutical and associated with Renowned Educational Institutions. At Syncorp Health, multiple functions work in tandem to bring new therapies & devices to market, our Clinical function “Syncorp Health” earlier “Syncorp Clincare” works together with customers to build the tailored made solutions for success. And our unique solutions deliver the value across Small to Mid-size to Large customer continuum. Have combined work experience in core aspects of Development of Partnerships and Alliances with companies, Business management, Leads and Accounts generation, Promotional activities of company and Clinical Operations. Board Member and President Syncorp Health, he brings over thirty (30) plus years of experience in Life Sciences & Health Care (LSHC) industry. Led the businesses in Strategic roles in companies like TCS LSHC, Wipro LSHC, Reliance, Biocon Ltd, Syneos Health & Cadila Pharmaceutical, experiences includes P&L leadership, building Offshoring, go-to-market strategies & Solutioning, Transitions, Transformation initiatives, & Quality Management services in Contract Research Organizations (CRO), BPO Life Sciences & Health Care (LSHC).

Freeman MW, et al. (2022) Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. NEJM, DOI: 10.1056/NEJMoa2213169. Tenet (2020)". Box Office Mojo. Archived from the original on 3 September 2020 . Retrieved 30 September 2020. By Qualification Deepak holds MBA Information Management, PG is Clinical Research and Certified External Quality Auditor. Heerspink HJL, et al. (2020) Dapagliflozin in patients with chronic kidney disease. NEJM, 383(15):1436–46.Dr. Arvind has obtained his MBA degree from the University of Birmingham. He completed his FRCP & MRCP from the Royal Colleges of Physicians, London & Glasgow, his MD from Bangalore Medical College and MBBS from St. John’s Medical College. Dunkirk (2017)". Box Office Mojo. Archived from the original on 23 December 2017 . Retrieved 23 December 2017. A Study of CIN-107 in Patients With Uncontrolled Hypertension Receiving 1 Antihypertensive Agent (HALO). Available from: https://www.clinicaltrials.gov/ct2/show/NCT05137002?term=cin-107&draw=2&rank=1 [Last accessed 28 Dec 2022] A Study of CIN-107 in Adults With Primary Aldosteronism (spark-PA). Available from: https://www.clinicaltrials.gov/ct2/show/NCT04605549?term=cin-107&draw=2&rank=3 [Last accessed 28 Dec 2021]

This announcement may include statements that are not statements of historical fact, or “forward-looking statements,” including with respect to AstraZeneca’s proposed acquisition of CinCor. Such forward-looking statements include, but are not limited to, the ability of AstraZeneca and CinCor to complete the transactions contemplated by the acquisition agreement, including the parties’ ability to satisfy the conditions to the consummation of the offer contemplated thereby and the other conditions set forth in the merger agreement, statements about the expected timetable for completing the transaction, AstraZeneca’s and CinCor’s beliefs and expectations and statements about the benefits sought to be achieved in AstraZeneca’s proposed acquisition of CinCor, the potential effects of the acquisition on both AstraZeneca and CinCor, the possibility of any termination of the acquisition agreement, as well as the expected benefits and success of baxdrostat and any combination product. These statements are based upon the current beliefs and expectations of AstraZeneca’s and CinCor’s management and are subject to significant risks and uncertainties. There can be no guarantees that the conditions to the closing of the proposed transaction will be satisfied on the expected timetable or at all or that baxdrostat or any combination product will receive the necessary regulatory approvals or prove to be commercially successful if approved. If underlying assumptions prove inaccurate or risks or uncertainties materialise, actual results may differ materially from those set forth in the forward-looking statements.

You want a partner that is as committed to your success as you are.

SYNCOPY, INC, Beverly Hills CA - Company Profile | BizStanding". bizstanding.com. Archived from the original on 7 June 2020 . Retrieved 7 June 2020. Christopher Nolan's 'Oppenheimer' Has Found Its Star and Release Date". Observer. 8 October 2021 . Retrieved 8 October 2021. Superior Court of The State of California for the County of Los Angeles" (PDF). The Hollywood Reporter. Archived (PDF) from the original on 6 June 2020 . Retrieved 19 May 2020. Marketing Material such as Manuscript writing, abstract preparation, case study writing, poster preparation, writing of review articles, newsletter

Besieged on all sides, SynCorp’s Five Factions are in retreat. The rebels aim to destroy the Company to free mankind. But does mankind really want to be freed? McMurray JJV, et al. (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. NEJM, 381(21):1995–2008. Wiviott SD, et al. (2019) Dapagliflozin and cardiovascular outcomes in type-2 diabetes [article and supplementary appendix]. NEJM, 380(4):347–57.Prior to joining Clinigene, he served as Consultant Physician at West Wales General Hospital, Wales UK between 1996-2000. He served as Medical Director of Mallya Hospital, Bangalore between 1990-1996 and was involved from concept to completion and running of the state-of-the-art tertiary referral hospital. He trained in the UK and India in Internal Medicine and Gastroenterology at St. Bartholomew Hospital and Broadgreen Hospital Liverpool, Victoria, St Martha’s and St John’s Medical College hospitals. CinCor Pharma Announces Topline Data for Phase 2 HALO Trial Evaluating Selective Aldosterone Synthase Inhibitor Baxdrostat in Uncontrolled Hypertension. Available from: https://www.cincor.com/news-releases/news-release-details/cincor-pharma-announces-topline-data-phase-2-halo-trial [Last accessed 30 Dec 2022]. Q&A: Christopher Nolan on the power of the people and why '2001' should be required preschool viewing". Los Angeles Times. Archived from the original on 12 April 2020 . Retrieved 19 May 2020. Our team and consultants have decade plus year of experience in clinical research, consulting, and services sector A Study to EvaluateCIN-107for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease. Available from: https://clinicaltrials.gov/ct2/show/NCT05432167?term=CIN-107&draw=2&rank=4 [Last accessed 28 Dec 2022].